The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Hyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-articular Biology for the Treatment of Knee Osteoarthritis
Abstract
Background: The use of platelet-rich plasma (PRP) for the treatment of osteoarthritis (OA) has demonstrated mixed clinical outcomes in randomized controlled trials when compared with hyaluronic acid (HA), an accepted nonsurgical treatment for symptomatic OA. Biological analysis of PRP has demonstrated an anti-inflammatory effect on the intra-articular environment. Purpose: To compare the clinical and biological effects of an intra-articular injection of PRP with those of an intra-articular injection of HA in patients with mild to moderate knee OA. Study Design: Randomized controlled trial; Level of evidence, 1. Methods: A total of 111 patients with symptomatic unilateral knee OA received a series of either leukocyte-poor PRP or HA injections under ultrasound guidance. Clinical data were collected before treatment and at 4 time points across a 1-year period. Synovial fluid was also collected for analysis of proinflammatory and anti-inflammatory markers before treatment and at 12 and 24 weeks after treatment. Several measures were used to assess results: (1) Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale; (2) International Knee Documentation Committee (IKDC) subjective knee evaluation, visual analog scale (VAS) for pain, and Lysholm knee score; and (3) difference in intra-articular biochemical marker concentrations. Results: There were 49 patients randomized to treatment with PRP and 50 randomized to treatment with HA. No difference was seen between the groups in the primary outcome measure (WOMAC pain score). In the secondary outcome measure, linear contrasts identified a significantly higher IKDC score in the PRP group compared with the HA group at 24 weeks (mean ± standard error [SE], 65.5 ± 3.6 vs 55.8 ± 3.8, respectively; P = .013) and at final follow-up (52 weeks) (57.6 ± 3.37 vs 46.6 ± 3.76, respectively; P = .003). Linear contrasts also identified a statistically lower VAS score in the PRP group versus the HA group at 24 weeks (mean ± SE, 34.6 ± 3.24 vs 48.6 ± 3.7, respectively; P = .0096) and 52 weeks (44 ± 4.6 vs 57.3 ± 3.8, respectively; P = .0039). An examination of fixed effects showed that patients with mild OA and a lower body mass index had a statistically significant improvement in outcomes. In the biochemical analysis, differences between groups approached significance for interleukin-1β (mean ± SE, 0.14 ± 0.05 pg/mL [PRP] vs 0.34 ± 0.16 pg/mL [HA]; P = .06) and tumor necrosis factor α (0.08 ± 0.01 pg/mL [PRP] vs 0.2 ± 0.18 pg/mL [HA]; P = .068) at 12-week follow-up. Conclusion: We found no difference between HA and PRP at any time point in the primary outcome measure: the patient-reported WOMAC pain score. Significant improvements were seen in other patient-reported outcome measures, with results favoring PRP over HA. Preceding a significant difference in subjective outcomes favoring PRP, there was a trend toward a decrease in 2 proinflammatory cytokines, which suggest that the anti-inflammatory properties of PRP may contribute to an improvement of symptoms. Registration: ClinicalTrials.gov (Identifier: NCT02588872).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.12.013 · Cited by 2,796 · cited 2×
“could not discern a difference in this younger, more active patient cohort.(26) The VAS score also favored PRP as compared with HA at 24 and 52 weeks, with a greater than 10-point difference at the 24- and 52-week follow-up visits.”
BackgroundRole of proinflammatory cytokines in the pathophysiology of osteoarthritis
Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J.-P., & Fahmi, H. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.196 · Cited by 2,778 · cited 3×
“In an effort to balance anabolism and catabolism in an affected joint, several biological treatments such as intraarticular PRP injections have been proposed.5,9,15,16,24 This strategy stems from biochemical research on anabolic growth factors, such as transforming growth factor b (TGF-b), insulin-like growth factor 1…”
BackgroundPlatelet-Rich Plasma (PRP): What Is PRP and What Is Not PRP?
Marx, R. E. (2001) · Implant Dentistry · doi:10.1097/00008505-200110000-00002 · Cited by 1,704
Dillon, C. F., Rasch, E. K., Gu, Q., & Hirsch, R. (2006) · PubMed · Cited by 815
Patel, S., Dhillon, M. S., Aggarwal, S., Marwaha, N., & Jain, A. (2013) · The American Journal of Sports Medicine · doi:10.1177/0363546512471299 · Cited by 762
The Role of Growth Factors in Cartilage Repair
Fortier, L. A., Barker, J. U., Strauss, E. J., McCarrel, T. M., & Cole, B. J. (2011) · Clinical Orthopaedics & Related Research · doi:10.1007/s11999-011-1857-3 · Cited by 642
Self-citationPlatelet-Rich Plasma: A Milieu of Bioactive Factors
Boswell, S. G., Cole, B. J., Sundman, E. A., Karas, V., & Fortier, L. A. (2012) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2011.10.018 · Cited by 613
Self-citationKon, E., Mandelbaum, B., Buda, R., Filardo, G., Delcogliano, M., Timoncini, A., Fornasari, P. M., Giannini, S., & Marcacci, M. (2011) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2011.05.011 · Cited by 582
Kon, E., Buda, R., Filardo, G., Di Martino, A., Timoncini, A., Cenacchi, A., Fornasari, P. M., Giannini, S., & Marcacci, M. (2010) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-009-0940-8 · Cited by 570
Filardo, G., Kon, E., Buda, R., Timoncini, A., Di Martino, A., Cenacchi, A., Fornasari, P. M., Giannini, S., & Marcacci, M. (2011) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-010-1238-6 · Cited by 475
Cerza, F., Carnì, S., Carcangiu, A., Di Vavo, I., Schiavilla, V., Pecora, A., De Biasi, G., & Ciuffreda, M. (2012) · The American Journal of Sports Medicine · doi:10.1177/0363546512461902 · Cited by 432
Riboh, J. C., Saltzman, B. M., Yanke, A. B., Fortier, L., & Cole, B. J. (2016) · The American Journal of Sports Medicine · doi:10.1177/0363546515580787 · Cited by 417
Self-citationSpaková, T., Rosocha, J., Lacko, M., Harvanová, D., & Gharaibeh, A. (2012) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e3182aab72 · Cited by 389
Filardo, G., Kon, E., Di Martino, A., Di Matteo, B., Merli, M. L., Cenacchi, A., Fornasari, P. M., & Marcacci, M. (2012) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-13-229 · Cited by 387
Corticosteroid injections for osteoarthritis of the knee: Meta-analysis
Arroll, B., & Goodyear-Smith, F. (2004) · BMJ · doi:10.1136/bmj.38039.573970.7c · Cited by 348 · cited 1×
“injections.(1,21,26) The latter is often the last treatment option preceding surgical intervention and includes the intra-articular administration of a corticosteroid or platelet-rich plasma (PRP) or viscosupplementation (hyaluronic acid [HA]).”
BackgroundChevalier, X., Jerosch, J., Goupille, P., van Dijk, N., Luyten, F. P., Scott, D. L., Bailleul, F., & Pavelka, K. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094623 · Cited by 283
Vaquerizo, V., Plasencia, M. Á., Arribas, I., Seijas, R., Padilla, S., Orive, G., & Anitua, E. (2013) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2013.07.264 · Cited by 259
Greco, N. J., Anderson, A. F., Mann, B. J., Cole, B. J., Farr, J., Nissen, C. W., & Irrgang, J. J. (2010) · The American Journal of Sports Medicine · doi:10.1177/0363546509354163 · Cited by 257
Self-citationScanzello, C. R., Umoh, E., Pessler, F., Diaz-Torne, C., Miles, T., DiCarlo, E., Potter, H. G., Mandl, L., Marx, R., Rodeo, S., et al. (2009) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2009.02.011 · Cited by 236
OP-1/BMP-7 in cartilage repair
Chubinskaya, S., Hurtig, M., & Rueger, D. C. (2007) · International Orthopaedics · doi:10.1007/s00264-007-0423-9 · Cited by 207
Laterally elevated wedged insoles in the treatment of medial knee osteoarthritis
Pham, T., Maillefert, J.-F., Hudry, C., Kieffert, P., Bourgeois, P., Lechevalier, D., & Dougados, M. (2003) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2003.08.011 · Cited by 184
Petrella, R. J., & Petrella, M. J. (2006) · PubMed · Cited by 145
Kirchner, M. ‐., & Marshall, D. C. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.09.003 · Cited by 121
Brandl, A., Angele, P., Roll, C., Prantl, L., Kujat, R., & Kinner, B. (2009) · Journal of Orthopaedic Research® · doi:10.1002/jor.21007 · Cited by 69
The protective effect of OP-1 on articular cartilage in the development of osteoarthritis
Badlani, N., Inoue, A., Healey, R., Coutts, R. D., & Amiel, D. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.09.009 · Cited by 56
Lawrence, J. T. R., Birmingham, J. D., & Toth, A. P. (2010) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-010-1699-4 · Cited by 44
Cited by
Belk, J. W., Kraeutler, M. J., Houck, D. A., Goodrich, J. A., Dragoo, J. L., & McCarty, E. C. (2021) · The American Journal of Sports Medicine · doi:10.1177/0363546520909397 · Cited by 432
Current Clinical Recommendations for Use of Platelet-Rich Plasma
Le, A. D. K., Enweze, L., DeBaun, M. R., & Dragoo, J. L. (2018) · Current Reviews in Musculoskeletal Medicine · doi:10.1007/s12178-018-9527-7 · Cited by 383
Platelets in wound healing and regenerative medicine
Etulain, J. (2018) · Platelets · doi:10.1080/09537104.2018.1430357 · Cited by 354
Filardo, G., Previtali, D., Napoli, F., Candrian, C., Zaffagnini, S., & Grassi, A. (2021) · CARTILAGE · doi:10.1177/1947603520931170 · Cited by 294
Di Martino, A., Di Matteo, B., Papio, T., Tentoni, F., Selleri, F., Cenacchi, A., Kon, E., & Filardo, G. (2019) · The American Journal of Sports Medicine · doi:10.1177/0363546518814532 · Cited by 272
Metadata
- Authors
- Cole, B. J., Karas, V., Hussey, K., Merkow, D. B., Pilz, K., & Fortier, L. A.
- Venue
- The American Journal of Sports Medicine
- Publisher
- SAGE Publications
- Published
- 2016-10-21
- Volume
- 45
- Issue
- 2
- Pages
- 339-346
- ISSN
- 0363-5465 (ISSN-L)
- 1552-3365
- OpenAlex
- W2535103699
- Cited by
- 405
- References
- 26
- FWCI
- 38.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.